title: Successful vemurafenib salvage treatment in a patient with primary refractory hairy cell leukemia and pulmonary aspergillosis.
authors: Department of Hematology and Oncology, University of Freiburg Medical Center, Hugstetter Straße 55, 79106, Freiburg, Germany, helga.maurer@uniklinik-freiburg.de.
authors: Helga
authors: H
authors: Maurer
authors: Peter
authors: P
authors: Haas
authors: Tobias
authors: T
authors: Wengenmayer
authors: Michael
authors: M
authors: Lübbert
authors: Justus
authors: J
authors: Duyster
authors: Robert
authors: R
authors: Zeiser
mesh_terms: D000890:Anti-Infective Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007211:Indoles / Q000494:pharmacology / Q000627:therapeutic use*; D055744:Invasive Pulmonary Aspergillosis / Q000188:drug therapy / Q000209:etiology* / Q000628:therapy; D007943:Leukemia, Hairy Cell / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D058990:Molecular Targeted Therapy; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors; D047428:Protein Kinase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D048493:Proto-Oncogene Proteins B-raf / Q000037:antagonists & inhibitors; D012074:Remission Induction; D012121:Respiration, Artificial; D016879:Salvage Therapy; D013449:Sulfonamides / Q000494:pharmacology / Q000627:therapeutic use*; D000077484:Vemurafenib
chemical_list: D000890:Anti-Infective Agents; D000970:Antineoplastic Agents; D007211:Indoles; D009363:Neoplasm Proteins; D047428:Protein Kinase Inhibitors; D013449:Sulfonamides; D000077484:Vemurafenib; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf